Linda Bailey
Surgical · Levittown, PANPI 1053369041
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by International Rehabilitative Sciences, Inc at 57.4% of the total. Reporting peaked in 2024 at $4,292 and has fallen 99.1% since, to $39 in 2025. Among surgical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $35.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Rehabilitative Sciences, Inc$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$783
- Collegium Pharmaceutical, Inc.$419
- AbbVie$411
- Pfizer$243
- Biohaven Pharmaceuticals, Inc.$178
- plus $826 from 12 others
What the payments were for
- Food & beverage$2,91343%
- Other$3,79557%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Rehabilitative Sciences, Inc | 3 | $3,848 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 70 | $783 |
| Collegium Pharmaceutical, Inc. | 25 | $419 |
| AbbVie(2 entities) | 28 | $411 |
| Pfizer | 13 | $243 |
| Biohaven Pharmaceuticals, Inc. | 8 | $178 |
| Redhill Biopharma Inc. | 8 | $111 |
| Almatica Pharma LLC | 4 | $105 |
| Forte Bio-pharma LLC | 2 | $102 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $98 |
| Azurity Pharmaceuticals, Inc. | 5 | $94 |
| Arbor Pharmaceuticals, Inc. | 5 | $90 |
| Valinor Pharma, LLC | 4 | $69 |
| Kowa Pharmaceuticals America, Inc. | 4 | $56 |
| Lilly USA, LLC | 2 | $35 |
| GRT US Holding, Inc. | 2 | $34 |
| Ossur Americas, Inc. | 1 | $18 |
| Orexo US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RS 4i Plus Sequential Stimulator$3,795
- RS-LBG, RS-FBG$3,795
How this compares
$6,708 in reported general payments places this provider in the 95th percentile of 626 surgical providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 49 | $115,696 |
| OxycontinOxycodone Hcl | 96 | $62,824 |
| Xtampza ErOxycodone Myristate | 66 | $48,739 |
| UbrelvyUbrogepant | 33 | $46,007 |
| Nurtec OdtRimegepant Sulfate | 22 | $39,078 |
| MovantikNaloxegol Oxalate | 92 | $36,624 |
| Oxycodone Hcl | 1,304 | $29,549 |
| Lidocaine | 104 | $12,413 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 224 | $7,314 |
| Morphine Sulfate ErMorphine Sulfate | 263 | $6,494 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 46 | $6,382 |
| Fentanyl | 32 | $5,338 |
| Pregabalin | 333 | $3,020 |
| Celecoxib | 69 | $2,875 |
| Methadone Hcl | 81 | $2,449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $783 | $115,69649 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $419 | $48,73966 claims |
| AbbVieUbrelvy | $411 | $46,00733 claims |
| PfizerNurtec Odt | $243 | $39,07822 claims |
| Redhill Biopharma Inc.Movantik | $111 | $36,62492 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 626 surgical providers in Pennsylvania.
Other surgical in Levittown
- Patsy SkablaWynnewood$188K
- Kyle LangstonAllentown$50K
- Aaron MacoskeyPittsburgh$40K
- Elissa CastorPittsburgh$25K
- Amanda YakobitisWynnewood$24K
- Dustin HobbsWilkes Barre$15K
- Leah KovalPittsburgh$13K
- Maureen SchullerLancaster$12K
- Margaryta TolchynskaMedia$11K
- Dino SacchettiDickson City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.